Dara-CyBorD

daratumumab + cyclophosphamide + bortezomib + dexamethasone · Johnson & Johnson ( Janssen )

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dara-CyBorD, covering 2019-04-03 to 2019-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma [Phase 2]